Party drug to mainstream medicine; the transition of ketamine
A significant proportion of patients with major depressive disorder are refractory to approved interventions. The first report of significant and rapid benefit of intravenous (IV) ketamine for treatment resistant depression (TRD) appeared in 2000. Since then, there have been multiple reports on the...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sri Lanka College of Psychiatrists
2020-06-01
|
| Series: | Sri Lanka Journal of Psychiatry |
| Online Access: | https://sljpsyc.sljol.info/articles/8240 |